extract: 2025-07-24-kff-medicare-advantage-2025-enrollment-update
Pentagon-Agent: Ganymede <F99EBFA6-547B-4096-BEEA-1D59C3E4028A>
This commit is contained in:
Teleo Agents
parent
1903674f1f
commit
92d5c2a2cd
5 changed files with 86 additions and 1 deletions
|
|
@ -23,6 +23,12 @@ Devoted was built from scratch on the Orinoco platform — a unified AI-native o
|
|||
|
||||
Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], UnitedHealth's $9 billion annual technology spend directed at optimizing existing infrastructure (consolidating 18 EMRs, AI scribing within legacy workflows) rather than rebuilding around prevention is textbook proxy inertia. The margin from coding arbitrage rationally prevents pursuit of the purpose-built alternative.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-15*
|
||||
|
||||
Market concentration data shows UHG gained 505K members while Humana lost 297K in 2025, suggesting the oligopoly is consolidating further toward the largest player. This creates the competitive environment where purpose-built entrants like Devoted can differentiate through technology rather than scale.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -29,6 +29,12 @@ Politicians face a choice between:
|
|||
|
||||
The political economy strongly favors Option A. The fiscal pressure builds continuously through the 2030s as the exhaustion date approaches, creating windows for reform regardless of partisan control.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-15*
|
||||
|
||||
The spending gap grew from $18B (2015) to $84B (2025), a 4.7x increase while enrollment only doubled. At 64% penetration by 2034 (CBO projection) with 20% per-person premium, annual overpayment will exceed $150B. The arithmetic forces reform regardless of political preferences.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -291,6 +291,12 @@ PACE provides the most comprehensive real-world test of the prevention-first att
|
|||
|
||||
The Commonwealth Fund's 2024 international comparison provides evidence that the prevention-first attractor state is not theoretical — peer nations demonstrate it empirically. The top performers (Australia, Netherlands) achieve better health outcomes with lower spending as percentage of GDP, suggesting their systems have structural features that prevent rather than treat. The US paradox (2nd in care process, last in outcomes, highest spending, lowest efficiency) reveals a system optimized for treating sickness rather than producing health. The efficiency domain rankings (US among worst — highest spending, lowest return) quantify the cost of a sick-care attractor state. The international benchmark shows that systems with better access, equity, and prevention orientation achieve superior outcomes at lower cost, suggesting the prevention-first attractor state is achievable and economically superior to the current US sick-care model.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-15*
|
||||
|
||||
C-SNP growth of 71% in one year shows MA plans are rapidly building chronic disease management infrastructure. With 21% of MA enrollment now in SNPs (up from 14% in 2020), the market is structurally shifting toward continuous care management models that align with prevention-first economics.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -0,0 +1,48 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-supplement-to-dominant-program.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "medicare-advantage-market-is-an-oligopoly-with-unitedhealthgroup-and-humana-controlling-46-percent-despite-nominal-plan-choice.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "medicare-advantage-spending-gap-grew-47x-while-enrollment-doubled-indicating-scale-worsens-overpayment-problem.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-disease-management-infrastructure.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 4,
|
||||
"kept": 0,
|
||||
"fixed": 4,
|
||||
"rejected": 4,
|
||||
"fixes_applied": [
|
||||
"medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-supplement-to-dominant-program.md:set_created:2026-03-15",
|
||||
"medicare-advantage-market-is-an-oligopoly-with-unitedhealthgroup-and-humana-controlling-46-percent-despite-nominal-plan-choice.md:set_created:2026-03-15",
|
||||
"medicare-advantage-spending-gap-grew-47x-while-enrollment-doubled-indicating-scale-worsens-overpayment-problem.md:set_created:2026-03-15",
|
||||
"chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-disease-management-infrastructure.md:set_created:2026-03-15"
|
||||
],
|
||||
"rejections": [
|
||||
"medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-supplement-to-dominant-program.md:missing_attribution_extractor",
|
||||
"medicare-advantage-market-is-an-oligopoly-with-unitedhealthgroup-and-humana-controlling-46-percent-despite-nominal-plan-choice.md:missing_attribution_extractor",
|
||||
"medicare-advantage-spending-gap-grew-47x-while-enrollment-doubled-indicating-scale-worsens-overpayment-problem.md:missing_attribution_extractor",
|
||||
"chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-disease-management-infrastructure.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-15"
|
||||
}
|
||||
|
|
@ -7,9 +7,13 @@ date: 2025-07-24
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: data
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [medicare-advantage, enrollment, market-concentration, market-share, kff]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-15
|
||||
enrichments_applied: ["medicare-fiscal-pressure-forces-ma-reform-by-2030s-through-arithmetic-not-ideology.md", "Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md", "the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -79,3 +83,18 @@ tags: [medicare-advantage, enrollment, market-concentration, market-share, kff]
|
|||
PRIMARY CONNECTION: [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
|
||||
WHY ARCHIVED: Essential market structure data — the enrollment trajectory and concentration metrics ground claims about where the US healthcare system is actually heading vs. where theory says it should go.
|
||||
EXTRACTION HINT: The spending gap growing 4.7x while enrollment only doubled is the key structural insight — scale is making the overpayment problem worse, not better.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- MA enrollment: 7.6M (19%) in 2007, 10.8M (25%) in 2010, 16.2M (32%) in 2015, 23.8M (42%) in 2020, 30.8M (51%) in 2023, 32.8M (54%) in 2024, 34.1M (54%) in 2025
|
||||
- CBO projects MA penetration will reach 64% by 2034
|
||||
- MA growth rate 2024-2025: 4% (1.3M additional enrollees)
|
||||
- 2025 MA market share: UnitedHealth 29%, Humana 17%, CVS/Aetna 12%, Elevance 7%, Kaiser 6%, all others 30%
|
||||
- 815 counties (26% of all US counties) have 75%+ enrollment concentration in UHG and Humana
|
||||
- Average beneficiary has 9 parent organization options; 36% have 10+ plan options
|
||||
- MA plan type distribution 2025: Individual 62%, SNPs 21%, Employer/union 17%
|
||||
- SNP breakdown 2025: D-SNPs 83%, C-SNPs 16%, I-SNPs 2%
|
||||
- C-SNP enrollment: 1.2M in 2025, 71% growth year-over-year
|
||||
- Total SNP enrollment: 7.3M (21% of MA) in 2025, up from 14% in 2020
|
||||
- Federal MA spending premium: $84B in 2025 (20% per-person), $18B in 2015
|
||||
- Employer/union group MA plans: first year of flat growth in ~10 years
|
||||
|
|
|
|||
Loading…
Reference in a new issue